The established risk of prostate cancer comorbidity in BRCA1/2 mutation carriers: Where is the clinically relevant hotspot for prostate cancer?

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)2289-2291
Number of pages3
JournalTranslational Andrology and Urology
Issue number5
Publication statusPublished - Oct 2020

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Urology

Cite this